Thomas Glott

Nesoddtangen, NO 
Nesoddtangen, NO 

Overview

Thomas Glott practices practicing medicine in Nesoddtangen, Norway.

His clinical expertise encompasses Neurogenic Bladder, Neurogenic Bowel, Fractured Spine, and Neuralgia.

He is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Nesoddtangen, Norway
Other Locations
Nesodden, Norway
Bjornemyrdalen, Norway
Sandvika, Norway
Alvaern, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prevention of Bladder Dysfunction in Acute Spinal Cord Injury. A Double-blind, Randomized, Placebo-controlled Study to Explore the Effect of Early Treatment With Onabotulinumtoxin A on Development of Detrusor Overactivity
Prevention of Bladder Dysfunction in Acute Spinal Cord Injury. A Double-blind, Randomized, Placebo-controlled Study to Explore the Effect of Early Treatment With Onabotulinumtoxin A on Development of Detrusor Overactivity
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Onabotulinumtoxin A
Study Phase: Phase 4
The ATLET Study: Can Subjects With Incomplete Spinal Cord Injury Learn to Walk? A Randomized Clinical Trial
The ATLET Study: Can Subjects With Incomplete Spinal Cord Injury Learn to Walk? A Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: September 11, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

27 Total Publications

Early intradetrusor injection of Onabotulinumtoxin A in patients with subacute spinal cord injury: The SCIBOT study.
Early intradetrusor injection of Onabotulinumtoxin A in patients with subacute spinal cord injury: The SCIBOT study.
Journal: Scandinavian journal of urology
Published: April 10, 2026

Frequently Asked Questions about Thomas Glott

Is Thomas Glott a top-rated expert for Neurogenic Bladder?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas Glott is classified as an Experienced expert for Neurogenic Bladder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas Glott participate in research or clinical trials?

Yes. Thomas Glott has published 27 articles and abstracts on conditions like Neurogenic Bladder. You can view a list of Thomas Glott's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Glott's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile